Total anomalous pulmonary venous connection pathophysiology

Total anomalous pulmonary venous connection Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Total anomalous pulmonary venous connection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
MRI
CT
Echocardiography
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Case Studies
Case #1
Total anomalous pulmonary venous connection pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Total anomalous pulmonary venous connection pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Total anomalous pulmonary venous connection pathophysiology
CDC on Total anomalous pulmonary venous connection pathophysiology
Total anomalous pulmonary venous connection pathophysiology in the news
Blogs on Total anomalous pulmonary venous connection pathophysiology
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Total anomalous pulmonary venous connection pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief:Cafer Zorkun, M.D., Ph.D. [2]; Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [[4]] Assistant Editor-In-Chief: Kristin Feeney, B.S. [[5]]

Pathophysiology

In patients of Total anomalous pulmonary venous connection (TAPVC)there is a mixing of oxygenated pulmonary venous blood with deoxygenated blood from systemic circulation

It mixing of blood could occur at three levels i.e. supracardiac, infracardiac and cardiac. In the former two the mixing occurs outside the heart and in latter inside the heart (right atrium).

This mixed deoxygenated blood is shunted from right-to-left side of heart(patent foramen ovale, atrial septal defect or patent ductus arteriosus). This right to left shunting causes cyanosis in the patient.

Since, the right side of heart is receiving blood both from pulmonary and systemic circulation it leads to development of pulmonary hypertension, right atrial and ventricular hypertrophy.

Obstructive form: In this pulmonary blood flow is restricted by the compression of pulmonary venous system by sorrounding structure or by the patency of pulmonary vein or vertebral vein. Level of obstructions seen are-

• Supracardiac (43%)
• Infracardiac (27%)
• Cardiac(18%)
• Mixed(12%)

Unobstructed forms — No significant stenosis of the pulmonary veins. {{#ev:youtube|eODH6E_OA_M}}

{{#ev:youtube|iiEI5TQ383w}}

Gross Pathology

Picture below shows cardiac type of TAPVC with opening of cardiac vein into right atrium

Picture below shows supracardiac type of TAPVC with connecting vertical vein